# Caris Life Sciences, Inc.: Form 8-K, filed Apr 2, 2026

- Company: [Caris Life Sciences, Inc.](/companies/cai.md) (CIK 2019410)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 16:28 ET
- Period: 2026-04-01
- Accession: 0002019410-26-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000019/cai-20260401.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2019410/000201941026000019/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2019410/000201941026000019/cai-20260401.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0002019410-26-000019. Last ingested by Listed: Nov 5, 2026, 13:53 ET. No prices; not investment advice.